Editorial Policies

Focus and Scope

Indonesia Natural Research Pharmaceutical Journal (INRPJ) is a scientific electronic journal published twice a year by Pharmacy Faculty of the Universitas 17 Agustus 1945 Jakarta.

The purpose of the Indonesia Natural Research Pharmaceutical Journal (INRPJ) is to publish manuscripts that significantly contribute to knowledge in all areas of 

Pharmacognosy,

Pharmacology and Toxicology,

Pharmaceutical Sciences,

Microbiology Pharmacy and Biotechnology Pharmacy,

Pharmacochemistry,

Pharmaceutical Technology,

Biochemistry,

Phytochemistry and

Herbal Medicine.

 

Section Policies

Articles

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Review

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Short Communication

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

Reviewer/Mitra Bestari

  1. Reviewer bertugas untuk membantu editor dalam meningkatkan kualitas naskah, membuat keputusan terhadap naskah yang masuk dengan mereview artikel sesuai dengan bidang keilmuannya
  2. Proses review naskah harus dilakukan secara objektif dan didukung dengan argumen yang jelas dan dapat dipertanggungjawabkan sesuai dengan kaidah ilmiah dan didukung dengan referensi yang berkualitas.
  3. Reviewer harus memastikan bahwa penulis telah mencantumkan sumber rujukan, referensi  atau data dalam penelitian.
  4. Dalam proses review, reviewer diminta untuk melaksanakan tugas sesuai dengan rentang waktu yang telah disepakati dan segera menginformasikan ke editor jika membutuhkan tenggang waktu.
  5. Reviewer diminta untuk melaporkan ke editor segala bentuk plagiarisme apabila ditemukan ketika melakukan kegiatan review.

 

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

 

Article Processing Charges

There is no charges for article’s submissions, evaluations and publication.

 

Screening Plagiarism

All manuscripts submitted in this journal will be checked, to avoid plagiarism cases. Articles that have a high plagiarism rate (above 20%) will be rejected.

 

Mitra Bestari/Peer Reviewers

Fenti Fatmawati, M.Si., Pharmacy Faculty, Universitas Bhakti Kencana

Anne Yuliantini, M.Si., Pharmacy Faculty, Universitas Bhakti Kencana

Dewi Kurnia, M.Si., Pharmacy Faculty, Universitas Bhakti Kencana. Scopus ID: 56730837600

Vina Juliana Anggraeni, M.Si., Pharmacy Faculty, Universitas Bhakti Kencana

Rosmaya Dewi, M.Si  Sekolah Tinggi Ilmu Kesehatan Bakti Tunas Husada Tasikmalaya. Scopus ID: 57210799769

Dimas Frananta Simatupang, M.Si, M.Sc Politeknik Teknologi Kimia Industri Medan. Scopus ID: 57201637128

Dina Soes Putri, M.Si, Universitas Muhammadiyah Mataram. Scopus ID: 57213606808

apt. Yeni, S.Farm.,M.Si. Universitas Muhammadiyah Prof. DR. HAMKA

 

Publication Ethics

PUBLICATION ETHICS

 

To maintain the quality of manuscript and avoid publishing violation / plagiarism in the process of publishing, the editorial board establishes scientific publication ethics. The publication ethics rules apply to writers/authors, editors, reviewers, and journal/editorial managers. The publication ethics refers to The Committee on Publication Ethics (COPE).

 

Author Ethics

1. Reporting; Authors must provide information about the process and result of their research to the editor honestly, clearly, and thoroughly, and file their research data properly and safely. The manuscript must contain sufficient details and references that enable others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable. The manuscript must follow journal submission guidelines.

2. Originality and plagiarism; Authors must ensure that the sent/submitted manuscript is original, written by themselves, derived from their own ideas and thoughts, and not plagiarizing other’s papers or ideas or thoughts. Authors are strictly prohibited from changing the cited reference names to other’s names.

 

3. Multiple or Concurrent Publication; Authors should not submit the same manuscript to more than one journal at the same time. It is unethical and unacceptable behavior. Multiple publications that originate from a research project must be clearly identified and refer to the main publication.

4. Acknowledgement of Source; Authors must acknowledge and cite all used and influential data sources in the book.

5. Multiple Submission; Authors must inform the editor that the manuscript has never been submitted to another journal publisher/publication. If there is a redundancy in submitting the manuscript to another publisher, the editor will reject the submitted manuscript.

6. Author Status; Authors must inform the editor that they have competence or qualification in a certain field or expertise in accordance with publishing science, namely librarianship. The Author who submitted the manuscript to the editor is the first author (co-author) so if a problem occurs in the process of publishing, it can be resolved immediately.  

7. Authorship of the Paper; Authors must describe individual contributions to their paper. The paper should be limited to those who have made a significant contribution to the conception, the design, the implementation or the interpretation of the reported study. Others who have contributed must be listed as co-author. In case the main contributors are listed as authors, those who have less contribution to research or publication are listed in the acknowledgment. Authors also ensure that they have seen and approved the submitted version of the manuscript and include their names as co-authors.

8. Fundamental Errors in the Paper; Authors must immediately inform the editor if errors are found in the paper, not only the results of the review but also of the edit. The errors include writing names, affiliations/agencies, quotes, and other writings that can reduce the meaning and substance of the paper. If that happens, the author must immediately propose improvements to the paper.

9. Disclosure and Conflicts of Interest; Authors must understand the scientific publications ethics above to avoid conflicts of interest with other parties, so that the paper can be processed smoothly and safely.

 

Editor Ethics

 

1. Publication Decisions; Based on the review report from the editorial board, editors may accept, reject, or request for modifications to the manuscript. The validation of the work in question and its importance to researchers and readers must always drive such decisions. The editors may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editors may confer with other editors or reviewers in making such a decision. The editors must be responsible for every material they publish and must have procedures and policies to ensure the quality of them and maintain the integrity of the published notes.

 

2. Review of Manuscripts; Editors must ensure that they initially evaluate each manuscript for originality. The editors should organize and use peer review fairly and wisely. The editors should explain their peer review processes in the information for authors and indicate in which parts of journals are peer reviewed. The editors should use appropriate peer reviewers for papers that are considered for publication by selecting people with sufficient expertise and avoiding those with conflicts of interest.

 

3. Fair Play; Editors must ensure that they evaluate each received manuscript for author’s intellectual content without regard to gender, sex, race, religious belief, citizenship, etc. An important part of the responsibility to make fair and unbiased decisions is the enforcement of editorial independence and integrity principles. The editors are in a strong position by making decisions about publication, which is crucial that this process is as fair as possible.

4. Confidentiality; Editors must ensure that information regarding the author's submitted manuscript must be guarded. The editors critically assess any potential violation of data protection and patient confidentiality.

 5. Disclosure and Conflicts of Interest; Editors do not use unpublished materials for their own research without the express written consent of the author. The editors do not involve in manuscript decisions that they have conflicts of interest. 

 

Reviewer Ethics

1. Objectivity and Neutrality; Reviewers must be honest, objective, unbiased, independent, and only take a side with scientific truth. The process of manuscript reviewing is expressed professionally without discriminating gender, sex, business side, ethnicity, religious belief, race, intergroup, and citizenship of the author. The reviewers must state their views clearly with supporting arguments.   

2. Confidentiality; Each manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorised by the editor.

3. Promptness; Any selected reviewers who feel unqualified/uninterested in reviewing the manuscript or do not have sufficient time to review should immediately notify the editor and withdraw from the planning process.

4. Accuracy; Reviewers must respond within a reasonable time frame. The reviewers only agree to review the manuscript if they are reasonably certain that they can return the review within the proposed or mutually agreed time frame, and inform the journal immediately if they require an extension. In case the reviewers find it impossible to complete a manuscript review within the exact time, the information must be communicated to the editor so that it can be sent to another reviewer.

5. Acknowledgement of Sources; Reviewers should ensure that the reference/ text citation is appropriate and credible (accountable). If errors or irregularities are found in the writing of reference/text citation, they must immediately inform the editor so the author can improve according to the notes from the reviewers. The reviewers must also state to the editor if there are substantial similarities or overlaps between the under consideration manuscript and any other published articles.

6. Peer- review effectiveness; Reviewers must respond to editor’s submitted manuscript and work according to the specified peer-review time (maximum 2 weeks). In case that a reviewer finds it impossible to complete a manuscript review within the allotted time, they must inform the editor so that the manuscript can be sent to another reviewer.

 

7. Disclosure and Conflict of Interest; Privileged information or ideas obtained through review process must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

 

Editorial Board

Prof. Dayar Arbain, Pharmacy Faculty, Universitas 17 Agustus 1945 Jakarta

Dr. Sumantri, Pharmacy Faculty, Universitas 17 Agustus 1945 Jakarta

Nina Jusnita, S.Tp., M.Si, Pharmacy Faculty, Universitas 17 Agustus 1945 Jakarta.

Prof. Naglaa Gamil Shehab, PhD, Dubai Pharmacy College for Girls

Prof. Dr. Habibah A. Wahab, School of Pharmaceutical Sciences, University Sains Malaysia (USM)